Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with ...

Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

A recent review concluded that artificial intelligence (AI) is rapidly transforming the diagnosis and treatment of haematological malignancies by enhancing diagnostic accuracy and ...

Hypertension may be silent, but its consequences are not. Early detection and timely treatment can prevent heart attacks, strokes, and kidney failure. As the country observes Philippine Heart Month, ...

The 2026 AHA/ASA guidelines for acute ischemic stroke introduce significant updates and first-ever pediatric stroke recommendations.

Blood pressure control remains elusive for most adults in the U.S. with hypertension, although they are typically close ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination with D-VRd. The regimen is approved for ...

A new scientific statement from the American Heart Association outlines maternal stroke risk and prevention and treatment strategies during pregnancy and postpartum.

Overview AI is emerging as a support tool in palliative care for blood cancer patients.Data-driven insights help clinicians ...